4-4) The Voice of Dr. Yan Ep77 • Meanwhile, the project of “The Key Research and Development Technologies and Applications of anti-Ebola therapeutic antibody MIL77” passed the formal examination by the Chinese Preventive Medicine Association for the Science and Technology Award in 2023 (#202311248001#). This is the top award for public health and preventive medicine from 🇨🇳 government. • The main researchers of the MIL77 project include Xiangguo Qiu, Generals Jiannan Feng and Beifen Shen in AMMS, and a group of scientists with PLA backgrounds. • According to the application for the award, MIL77 is a great achievement by Chinese scientists, which got the thumbs up from Xi Jinping in 2015. • However, MIL77 is a near copy of a cocktail of anti-Ebola antibodies known as ZMapp. ZMapp is originally developed with support from U.S. and Canadian military research agencies. So MIL77 contains patents in ZMapp, which are held by 🇺🇸 government and Her Majesty the Queen in Right of 🇨🇦. When Qiu worked in the National Lab in Winnipeg, she was deeply involved in the development of ZMapp. • After raising patent infringement concerns, two Chinese military-civil fusion pharmaceutical companies, Beijing Mabworks and Hisun, claimed the development and manufacturing of MIL77 were “motivated to fight a global emergency” with support from the 🇨🇳 government. • In 2016, Mabworks and Hisun appeared in authorship of a study on MIL77 and ZMapp, with Qiu and the US-Canada team owning the patents of ZMapp. That study is also listed in the award application above as the major supportive material. • Full article & broadcast👇🏻